• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Home
  • DOPT ORDERS 2020
  • FinMin Orders 2020
  • Railway Orders 2020
  • Contact Us

7th Pay Commission Latest news

Central Government Employees News

  • DOPPW Orders
  • 7th Pay Commission
  • Dearness Allowance
  • Dearness Relief
  • CSD Price List
  • Defence
    • Defence Pension
You are here: Home / COVID-19 / Myths & Facts on India’s Vaccination Process – NITI Aayog

Trending
FINMIN Order : Dearness Allowance to Central Government employees from Jan 2022 “hot”
AICPIN for the month of March 2022 “hot”
GPF Interest Rate from April 2022 to June 2022 “hot”
Small Savings Schemes Interest Rate from April 2022 to June 2022 “hot”

Myths & Facts on India’s Vaccination Process – NITI Aayog

May 27, 2021 pcadmin Leave a Comment

Myths & Facts on India’s Vaccination Process – NITI Aayog

Several myths on India’s Covid-19 vaccination program are doing the rounds. These myths are arisingdue to distorted statements, half truths and blatant lies.

Member (Health) in NITI Aayog and Chair of the National Expert Group on Vaccine Administration for COVID-19 (NEGVAC) Dr Vinod Paul addresses these myths and gives out facts on all these issues.

Here are the myths & facts.

Myth 1: Centre is not doing enough to buy vaccines from abroad

Fact: The Central Government has remained engaged continuously with all the major international vaccine manufacturers right from mid-2020. Multiple rounds of discussions have happened with Pfizer, J&J & Moderna. Government offered all assistance to have them supply and /or manufacture their vaccines in India. However, it is not that their vaccines are available in free supply. We need to understand that buying vaccines internationally is not similar to buying ‘off the shelf’ items. Vaccines are in limited supply globally, and companies have their own priorities, game-plans and compulsions in allocating finite stocks. They also give preference to countries of their origin just as our own vaccine makers have done unhesitatingly for us. As soon as Pfizer indicated vaccine availability, Central Government and the company are working together for the earliest possible import of the vaccine. As a result of GoI’s efforts, Sputnik vaccine trials got accelerated and  with timely approval, Russia has already sent two tranches of vaccines & accomplishedtech-transfer to our companies that would start manufacturing very soon. We reiterate our request to all international vaccine makers to come and make in India – for India and for the world.

 Myth 2: Centre has not approved vaccines available globally

Fact: The Central Government has proactively eased entry of vaccines approved by US FDA, EMA, UK’s MHRA and Japan’s PMDA, and WHO’s Emergency Use Listing into India in April. These vaccines will not need to undergo prior bridging trials. The provision has now been further amended to waive off the trial requirement altogether for the well-established vaccines manufactured in other countries. No application of any foreign manufacturer for approval is pending with the drugs controller.

Myth 3: Centre is not doing enough to ramp up domestic production of vaccines

Fact: The Central Government is playing the role of an effective facilitator to enable more companies to produce vaccines from the early 2020. There is only 1 Indian company (Bharat Biotech) which has the IP. GoI has ensured that 3 other companies/plants will start production of Covaxin apart from enhancing Bharat Biotech’s own plants, which have increased from 1 to 4. Covaxin production by Bharat Biotech is being increased from under 1 Cr per month to 10 Cr month by October.  Additionally, the three PSUs will together aim to produce upto 4.0 Cr doses by December. With constant encouragement of the Government, Serum Institute is ramping up Covishield production of 6.5 crore doses per month to 11.0 crore doses per month. GoI is also ensuring in partnership with Russia that Sputnik will be manufactured by 6 companies coordinated by Dr Reddy’s. The Union Government is supporting efforts of Zydus Cadila, BioE as well Gennova for their respective indigenous  vaccines through liberal funding under Covid Suraksha scheme as also the technical support at national laboratories. Development of Bharat Biotech’s single dose intranasal vaccine is proceeding well with GoI funding, and it could be a game-changer for the world. The estimate of production of over 200  crore doses by our vaccine industry by the end of 2021 is the result of such efforts and unstinted support and partnership. How many countries can even dream of such an enormous capacity, and that too across conventional as well as cutting-edge DNA and mRNA platforms? GoI and vaccine manufacturers have worked as one Team India in this mission with seamless engagement on daily basis.

Myth 4: Centre should invoke compulsory licensing

Fact: Compulsory Licensing is not a very attractive option since it is not a ‘formula’ that matters, but active partnership, training of human resources, sourcing of raw materials and highest levels of bio-safety labs which is required. Tech transfer is the key and that remains in the hands of the company that has carried out R&D. Infact, we have gone one step ahead of Compulsory Licensing and are ensuring active partnership between Bharat Biotech & 3 other entities to enhance production of Covaxin. Similar mechanism is being followed for Sputnik. Think about this: Moderna had said in October 2020 that it will not sue any company which makes its vaccines, but still not one company has done it, which shows licensing is the least of the issues. If vaccine-making was so easy, why would even the developed world be so short of vaccine doses?

Myth 5: Centre has abdicated its responsibility to the states

Fact:The Central Government is doing all the heavy-lifting, from funding vaccine manufacturers to giving them quick approvals to ramping up production to bringing foreign vaccines to India. The vaccine procured by the Centre is supplied wholly to the states for free administration to people.  All this is very much in the knowledge of the states. GoI has merely enabled states to try procuring vaccines on their own, on their explicit requests. The states very well knew the production capacity in the country and what the difficulties are in procuring vaccines directly from abroad. In fact, GoI ran the entire vaccine program from January to April & it was quite well-administrated compared to the situation in May. But states, who had not even achieved good coverage of healthcare workers and frontline workers in 3 months wanted to open up the process of vaccination and wanted more decentralisation. Health is a state subject & the liberalised vaccine policy was a result of the incessant requests being made by the states to give states more power. The fact that global tenders have not given any results only reaffirm what we have been telling the states from day one: that vaccines are in short supply in the world and it is not easy to procure them at short notice.

Myth 6: Centre is not giving enough vaccines to the states

Fact: Centre is allotting enough vaccines to the states in a transparent manner as per agreed guidelines. In fact, states are also being informed in advance of the vaccine availability. Vaccine availability is going to increase in near future and much more supply would be possible. In the non-GoI channel, states are getting 25% of the doses and private hospitals are getting 25% doses. However the hiccups and issues faced by the people in the administration of these 25% doses by the states leave a lot to be desired. The behaviour of some of our leaders, who in spite of full knowledge of the facts on vaccine supply, appear on TV daily and create panic among the people is very unfortunate. This is not the time to play politics. We need everyone to unite in this fight.   

Myth 7: Centre is not taking any step to vaccinate children

Fact: As of now, no country in the world is giving vaccines to children. Also, WHO has no recommendation on vaccinating children. There have been studies about safety of vaccines in children,which have been encouraging. Trials in children in India are also going to begin soon. However, vaccinating children should not be decided on the basis of panic in Whatsapp groups and because some politicians want to play politics. It has to be a decision taken by our scientists after adequate data is available based on trials.

**********

PIB

Filed Under: COVID-19

Also Read

AICPIN for the month of June 2022

AICPIN for the month of June 2022

July 30, 2022 By pcadmin Leave a Comment

AICPIN for the month of June 2022 GOVERNMENT OF INDIAMINISTRY OF LABOUR & EMPLOYMENTLABOUR BUREAU F.No. 5/1/2021-CPI `CLEREMONT', SHIMLA-171004 DATED: 29 July, 2022 Press Release Consumer Price Index for Industrial Workers (2016=100) - June, 2022 The Labour Bureau, an attached … [Read More...] about AICPIN for the month of June 2022

Providing Form 16 to all pensioners and family pensioners

Providing Form 16 to all pensioners and family pensioners

August 8, 2022 By pcadmin Leave a Comment

Providing Form 16 to all pensioners and family pensioners GOVERNMENT OF INDIAMINISTRY OF FINANCEDEPARTMENT OF EXPENDITURECENTRAL PENSION ACCOUNTING OFFICETRIKOOT-II, BHIKAJI CAMA PLACE,NEW DELHI-110066 CPAO/IT&Tech/BankPerformance/37Vol-III(A)/101636/2022-23/124 19/07/2022 Office … [Read More...] about Providing Form 16 to all pensioners and family pensioners

Recruitment of 10 lakh people by Government - Rajya Sabha QA

Recruitment of 10 lakh people by Government – Rajya Sabha QA

August 8, 2022 By pcadmin Leave a Comment

Recruitment of 10 lakh people by Government - Rajya Sabha QA GOVERNMENT OF INDIAMINISTRY OF PERSONNEL, PUBLIC GRIEVANCES AND PENSIONS(DEPARTMENT OF PERSONNEL & TRAINING) RAJYA SABHAUNSTARRED QUESTION NO. 2196(TO BE ANSWERED ON 04.08.2022) RECRUITMENT OF 10 LAKH PEOPLE BY … [Read More...] about Recruitment of 10 lakh people by Government – Rajya Sabha QA

8th Central Pay Commission to revise salaries, allowances and pension - Rajya Sabha Q&A

8th Central Pay Commission to revise salaries, allowances and pension – Rajya Sabha Q&A

August 5, 2022 By pcadmin Leave a Comment

8th Central Pay Commission to revise salaries, allowances and pension - Rajya Sabha Q&A GOVERNMENT OF INDIAMINISTRY OF FINANCEDEPARTMENT OF EXPENDITURE RAJYA SABHAUNSTARRED QUESTION No. 1807TO BE ANSWERED ON TUESDAY, AUGUST 02, 2022SRAVANA 11, 1944 (SAKA) “Review of … [Read More...] about 8th Central Pay Commission to revise salaries, allowances and pension – Rajya Sabha Q&A

Increase in DA/DR to Government employees/pensioners - Rajya Sabha QA

Increase in DA/DR to Government employees/pensioners – Rajya Sabha QA

August 4, 2022 By pcadmin Leave a Comment

Increase in DA/DR to Government employees/pensioners - Rajya Sabha QA Government of IndiaMinistry of FinanceDepartment of Expenditure Rajya SabhaUnstarred Question No. 1806To be answered on Tuesday, 2nd August, 2022Sravana 11, 1944 (Saka) Increase in DA/DR to Government … [Read More...] about Increase in DA/DR to Government employees/pensioners – Rajya Sabha QA

Travelling Allowance on transfer to/from North-Eastern Region, Union Territories of Andaman & Nicobar, Lakshadweep Island and Ladakh – In respect of Railway employees.

Travelling Allowance on transfer to/from NER, UT of A&N, Lakshadweep Island and Ladakh for Railway Employees

August 2, 2022 By pcadmin Leave a Comment

Travelling Allowance on transfer to/from North-Eastern Region, Union Territories of Andaman & Nicobar, Lakshadweep Island and Ladakh – In respect of Railway employees. GOVERNMENT OF INDIA (भारत सरकार)MINISTRY OF RAILWAYS (रेल मंत्रालय)RAILWAY BOARD (रेलवे बोर्ड) PC VII No. 185RBE No, … [Read More...] about Travelling Allowance on transfer to/from NER, UT of A&N, Lakshadweep Island and Ladakh for Railway Employees

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

All About Pension

All about Pension

Latest DOPT Orders

Covid Vaccination Amrit Mahotsav – Free Precaution Dose to all Central Government Employees

Closure of Offices/buildings in connection with Swearing-in-ceremony of the President-elect of India on 25.07.2022

Central Government Offices Holiday List 2023: DOPT ORDER

Inclusion of sports disciplines for recruitment of meritorious sports persons to any post in Group ‘C’ – DOPT

Paid Holiday: Bye election to three (3) Parliamentary Constituencies and seven (7) Assembly Constituencies of various States on 23.06.2022

Latest Finmin Orders

GPF Interest Rate from July 2022 to September 2022

Travelling Allowance on transfer to/from North-Eastern Region, Union Territories of Andaman & Nicobar, Lakshadweep Islands and Ladakh

CGEGIS 1980 – Table of Benefits from April to June 2022

FINMIN Order : Dearness Allowance to Central Government employees  from Jan 2022

Modification of instructions regarding Air Travel on Government account. – FINMIN

Latest Railway Orders

Computer Advance Interest Rate 2022-23 for Railway Employees

Eligibility of married disabled child for family pension – Railway Board order

Grant of Leave to Probationary officers: Railway Board

Productivity Linked Bonus to all eligible non-gazetted Railway employees for 2020-2021

Cabinet approves Productivity Linked Bonus to Railway Employees for the year 2020-21

Categories

Copyright © 2022